Diabetes Care Market Report 2026

The diabetes care market size has grown strongly in recent years. It will grow from $29.09 billion in 2025 to $31.63 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing diabetes prevalence, hospital-based diabetes management, reliance on finger-stick testing, lifestyle changes, aging population.

The diabetes care market size is expected to see strong growth in the next few years. It will grow to $43.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growth of digital health solutions, expansion of connected devices, rising homecare adoption, improved insulin delivery systems, increasing patient self-management. Major trends in the forecast period include rising adoption of continuous glucose monitoring, growth of home-based diabetes care, expansion of insulin pump usage, integration of digital diabetes management tools, focus on personalized diabetes treatment.

The rising prevalence of obesity is expected to drive the growth of the diabetes care market in the coming years. Obesity rates indicate the proportion of the population with a body mass index (BMI) of 30 or higher, signifying obesity. Increasing obesity levels are largely attributed to greater adoption of sedentary lifestyles along with the widespread consumption of highly processed, calorie-dense foods that offer low nutritional value, leading to an imbalance between calorie intake and physical activity. Diabetes care plays a vital role in managing the effects of rising obesity by encouraging healthier lifestyle habits, enhancing glucose control, and supporting weight management through advanced solutions such as insulin therapy and continuous glucose monitoring systems. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government organization, between 2023 and 2024, approximately 64.5% of adults aged 18 and above in England were overweight or living with obesity, up from 64% during 2022 to 2023. Therefore, increasing obesity rates are contributing to the expansion of the diabetes care market.

Major companies operating in the diabetes care market are concentrating on the development of advanced technologies, including automated insulin delivery (AID) systems, to enhance glucose management by integrating continuous glucose monitoring (CGM) systems with insulin pumps for real-time insulin adjustments. An automated insulin delivery system is a technology that combines a CGM with an insulin pump to automatically regulate insulin dosing based on real-time glucose readings, improving diabetes management. For instance, in February 2024, Tandem Diabetes Care Inc., a US-based manufacturer of diabetes medical devices, launched the Tandem Mobi, described as the world’s smallest and most durable automated insulin delivery device. This device features a discreet, tubed insulin pump that can be fully controlled through a smartphone application, allowing users to manage their diabetes without a traditional handheld controller. The Tandem Mobi is waterproof, rechargeable, and integrates with Dexcom’s CGM system to automate insulin delivery using Tandem’s Control-IQ technology.

In January 2023, Tandem Diabetes Care Inc., a US-based diabetes technology and insulin delivery company, acquired AMF Medical SA for an undisclosed amount. Through this acquisition, Tandem Diabetes Care aims to accelerate the development and commercialization of advanced patch pump technology, expand its product portfolio, and reach a wider patient base. AMF Medical SA is a Switzerland-based company specializing in medical technologies for diabetes management, with a focus on insulin delivery solutions.

Major companies operating in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy's Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.

North America was the largest region in the diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the diabetes care market by increasing costs of imported glucose monitoring devices, insulin pumps, and electronic components. Hospitals and homecare users in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher device affordability challenges. These tariffs are increasing care costs. However, they are encouraging domestic device manufacturing and regional innovation.

The diabetes care market research report is one of a series of new reports that provides diabetes care market statistics, including diabetes care industry global market size, regional shares, competitors with a diabetes care market share, detailed diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care industry. This diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diabetes care involves the comprehensive management and treatment of diabetes mellitus, a chronic disorder marked by elevated blood glucose levels. It includes a combination of medical, lifestyle, and technological approaches designed to keep blood sugar within a target range and reduce the risk of complications.

The primary product types in diabetes care include glucose monitoring devices, insulin pumps, and others. Glucose monitoring devices are medical instruments used to measure and monitor blood glucose levels, mainly for people with diabetes. The different diabetes types include type 1 diabetes, type 2 diabetes, and others, and these products are utilized by various end users such as hospitals and clinics, home care settings, ambulatory care centers, and others.

The diabetes care market consists of revenues earned by entities by providing services such as insulin therapy and medication management, nutrition and diet planning, lifestyle modification support, and telemedicine and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes care market also consists of sales of products including dietary and nutritional products, medication delivery devices, and digital and software solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.